- Women’s Gymnastics Brings High Risk for Concussion
- Move to ‘Zero-Emission’ Vehicles Would Save 90,000 U.S. Lives by 2050
- Smoke From Canadian Wildfires Blackens Skies, Prompts Air Quality Alerts in Much of U.S.
- FDA Finalizes Limit on How Much Arsenic Can Be in Apple Juice
- As Medical Debt Rises, So Do Cancer Death Rates
- Patients With Bladder Cancer May Avoid Removal of Extra Lymph Nodes, Study Finds
- Your Risk of COVID-Linked Smell Loss Is Much Lower Now: Study
- Going Solo: Masturbation May Give Humans an Evolutionary Edge
- Kids With ADHD, Behavior Issues Have Poorer Trajectories as Adults
- Gene-Targeted Drug Tagrisso Cuts Death Rate in Half for Patients With Early-Stage Lung Cancer
Personalized ‘Pills’ From a 3D Printer?

With 3D printing, the concept of personalized medicine could take on a new dimension, researchers report.
Mass-produced drugs can’t take into account specific patient characteristics such as race, weight, and kidney and liver functions. Customized medications, on the other hand, might be more effective and less likely to cause side effects, the researchers said.
For this study, investigators from Wake Forest University, Columbia University and the University of North Carolina created a prototype computer algorithm featuring software for 3D printing of personalized medications. After receiving details about a patient’s specific medical and biological characteristics, the software determines personalized doses and provides data for 3D printing of medications.
Five doses of 80 “pills” — ranging from 124 to 373 milligrams — were created through 3D printing, with little variability, the researchers said.
The findings show that using 3D printing to create customized medications is possible. But, further research is needed before this technology might become available for patients, said Dr. Min Pu, of Wake Forest University School of Medicine, and colleagues in an American Heart Association news release.
The study was to be presented Monday at the American Heart Association’s annual meeting in Orlando, Fla. Data and conclusions presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.
More information
The U.S. National Institutes of Health has more about personalized medicine.
There’s more on heart attack prevention at the U.S. National Heart, Lung, and Blood Institute.
Source: HealthDay
Copyright © 2023 HealthDay. All rights reserved.